• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% studentrabatt med kod TERM26

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Klinisk medicin och internmedicin
    3. Sjukdomar och rubbningar
    4. Onkologi

    Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies

    AvChi Hin Cho,Tao Hu

    Inbunden, Engelska, 2020

    Del 8 i serien Cancer Sensitizing Agents for Chemotherapy

    1 760 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies, Volume Eight, summarizes the molecular mechanisms of drug resistance in colorectal cancer, along with the most up-to-date therapeutic strategies available. The book discusses reasons why colorectal tumors become refractory during the progression of the disease, but also explains how drug resistance occurs during chemotherapy. In addition, users will find the current therapeutic strategies used by clinicians in their practice in treating colorectal cancer. The combination of conventional anticancer drugs with chemotherapy-sensitizing agents plays a pivotal role in improving the outcome of colorectal cancer patients, in particular those with drug-resistant cancer cells.

    From a clinical point-of-view, the content of this book provides clinicians with updated therapeutic strategies for a better choice of drugs for drug-resistant colorectal cancer patients. It will be a valuable source for cancer researchers, oncologists and several members of biomedical field who are dedicated to better treat patients with colorectal cancer.



    • Presents a systemic summary of molecular mechanisms for a quick and in-depth understanding
    • Updates current trends in the field with pioneering information on drug resistance
    • Encompasses both basic and clinical approaches for a better understanding of unsolved problems from a holistic point-of-view

    Produktinformation

    • Utgivningsdatum:2020-05-27
    • Mått:191 x 235 x undefined mm
    • Vikt:660 g
    • Format:Inbunden
    • Språk:Engelska
    • Serie:Cancer Sensitizing Agents for Chemotherapy
    • Antal sidor:240
    • Förlag:Elsevier Science
    • ISBN:9780128199374

    Utforska kategorier

    • Onkologi inom Medicin
    • Biologi inom Naturvetenskap och teknik

    Mer om författaren

    Professor Chi Hin Cho is Distinguished Professor of Pharmacology at Southwest Medical University in China. His current research interests focus on drug development for inflammation and cancers in the gastrointestinal tract. He has served on leading journals in the fields of gastroenterology and pharmacology and as editor of seven books related to inflammation and cancer. He has held numerous senior positions, including the Chair of Pharmacology at Hong Kong University, Chairman and Professor of Pharmacology at the Chinese University of Hong Kong (CUHK), and Research Professor and Associate Director of the School of Biomedical Sciences in the Faculty of Medicine, CUHK. Professionally, he was the President (2006–2010) and Chair of the Presidential Council (2012–2015) of the Gastrointestinal Pharmacology Section of the International Union of Basic and Clinical Pharmacology, and council member of a number of professional bodies in ulcer research and gastrointestinal pharmacology. Dr. Hu obtained his Ph.D. from The Chinese University of Hong Kong, his research interests focus on the development of novel chemotherapeutic agents for the treatment of colorectal cancer, in particular the drug-resistant colorectal cancer. He published more than 20 peer-reviewed papers in this field and served as editorial board member or reviewer for more than 10 international journals in the field of pharmacology and gastroenterology.

    Innehållsförteckning

    • 1. Drug resistence in colorectal cancer: General aspects2. Drug transporters in the development of multidrug resistance in colorectal cancer3. Role pf colorectal cancer stem cells in resistance to apoptosis and treatment in colorectal cancer4. Serrated lesions and stem cells on drug resistance and colon cancer5. Development of novel microRNA-based therapeutics platform for colorectal cancer6. Chemo-sensitizing agents for naturalorigin for colorectal cancer: Pharmacokinetics approaches7. Induction of programmed necrosis by phytochemicals in colorectal cancer8. Predictive biomarkers of drug resistance in colorectal cancer - Recent updates9. Raclb: An emerging therapeutic target for chemoresistance in colorectal cancer10. Nanotechnology-based targeted drug delivery systems and drug resistance in colorectal cancer11. Targeting colorectal cancer via nanodrug delivery systems